What was GlaxoSmithKline Pharmaceuticals Ltd's net profit in Q3?

GlaxoSmithKline Pharmaceuticals Ltd reported a net profit of ₹295.6 crore for the third quarter, marking a 28.6% increase year-on-year.

How much did GlaxoSmithKline Pharmaceuticals Ltd's revenue grow in the third quarter?

The company's revenue for the third quarter grew by 9.7% to ₹1,041 crore compared to the same period last year.

What caused the increase in employee benefits expense for GlaxoSmithKline Pharmaceuticals Ltd?

The increase in employee benefits expense was due to the Government of India's notification of the four Labour Codes, leading to a change in wage definition.

Home / Business and Economy / GSK Pharma Profit Soars 28.6% on Strong Q3 Earnings

GSK Pharma Profit Soars 28.6% on Strong Q3 Earnings

9 Feb

•

Summary

Net profit surged 28.6% year-on-year to ₹295.6 crore in Q3.
Quarterly revenue grew 9.7% to ₹1,041 crore.
Employee benefits expense increased due to new Labour Codes.

GSK Pharma Profit Soars 28.6% on Strong Q3 Earnings

GlaxoSmithKline Pharmaceuticals Ltd announced a significant 28.6% year-on-year rise in net profit for its third quarter, culminating in ₹295.6 crore. This financial achievement builds upon a 9.7% increase in revenue, which reached ₹1,041 crore compared to the same period last year.

The company's operational efficiency is further highlighted by a 27.2% year-on-year growth in EBITDA and an improved operating margin of 35.6%. A notable factor influencing expenses was the Government of India's notification of four Labour Codes, leading to an ₹11.82 crore increase in employee benefits.

For the nine months ending December 31, 2025, total income rose to ₹2,935.78 crore, with net profit significantly higher at ₹758.12 crore. The company continues to monitor developments related to the Labour Codes and will adjust accounting as necessary.